Indonesia · Delayed Price · Currency is IDR PT Medikaloka Hermina Tbk Statistics
Total Valuation
IDX:HEAL has a market cap or net worth of IDR 19.13 trillion. The enterprise value is 23.16 trillion.
| Market Cap | 19.13T |
| Enterprise Value | 23.16T |
Important Dates
The next estimated earnings date is Wednesday, April 15, 2026.
| Earnings Date | Apr 15, 2026 |
| Ex-Dividend Date | May 5, 2025 |
Share Statistics
IDX:HEAL has 15.37 billion shares outstanding. The number of shares has increased by 1.90% in one year.
| Current Share Class | 15.37B |
| Shares Outstanding | 15.37B |
| Shares Change (YoY) | +1.90% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 26.51% |
| Owned by Institutions (%) | 5.82% |
| Float | 8.19B |
Valuation Ratios
The trailing PE ratio is 43.84 and the forward PE ratio is 34.20. IDX:HEAL's PEG ratio is 2.16.
| PE Ratio | 43.84 |
| Forward PE | 34.20 |
| PS Ratio | 2.68 |
| PB Ratio | 2.65 |
| P/TBV Ratio | 3.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 16.81 |
| PEG Ratio | 2.16 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.08, with an EV/FCF ratio of -37.84.
| EV / Earnings | 53.92 |
| EV / Sales | 3.25 |
| EV / EBITDA | 13.08 |
| EV / EBIT | 23.91 |
| EV / FCF | -37.84 |
Financial Position
The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.45.
| Current Ratio | 1.22 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | 1.82 |
| Debt / FCF | -5.27 |
| Interest Coverage | 4.06 |
Financial Efficiency
Return on equity (ROE) is 8.40% and return on invested capital (ROIC) is 7.34%.
| Return on Equity (ROE) | 8.40% |
| Return on Assets (ROA) | 5.39% |
| Return on Invested Capital (ROIC) | 7.34% |
| Return on Capital Employed (ROCE) | 9.74% |
| Weighted Average Cost of Capital (WACC) | 4.40% |
| Revenue Per Employee | 382.78M |
| Profits Per Employee | 23.05M |
| Employee Count | 18,636 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 31.62 |
Taxes
In the past 12 months, IDX:HEAL has paid 205.92 billion in taxes.
| Income Tax | 205.92B |
| Effective Tax Rate | 27.28% |
Stock Price Statistics
The stock price has increased by +21.50% in the last 52 weeks. The beta is -0.00, so IDX:HEAL's price volatility has been lower than the market average.
| Beta (5Y) | -0.00 |
| 52-Week Price Change | +21.50% |
| 50-Day Moving Average | 1,304.70 |
| 200-Day Moving Average | 1,470.63 |
| Relative Strength Index (RSI) | 40.72 |
| Average Volume (20 Days) | 11,686,265 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:HEAL had revenue of IDR 7.13 trillion and earned 429.55 billion in profits. Earnings per share was 28.40.
| Revenue | 7.13T |
| Gross Profit | 2.28T |
| Operating Income | 968.53B |
| Pretax Income | 754.88B |
| Net Income | 429.55B |
| EBITDA | 1.77T |
| EBIT | 968.53B |
| Earnings Per Share (EPS) | 28.40 |
Balance Sheet
The company has 727.79 billion in cash and 3.23 trillion in debt, with a net cash position of -2,497.57 billion or -162.54 per share.
| Cash & Cash Equivalents | 727.79B |
| Total Debt | 3.23T |
| Net Cash | -2,497.57B |
| Net Cash Per Share | -162.54 |
| Equity (Book Value) | 7.21T |
| Book Value Per Share | 369.43 |
| Working Capital | 427.68B |
Cash Flow
In the last 12 months, operating cash flow was 1.14 trillion and capital expenditures -1,749.99 billion, giving a free cash flow of -612.15 billion.
| Operating Cash Flow | 1.14T |
| Capital Expenditures | -1,749.99B |
| Depreciation & Amortization | 798.50B |
| Net Borrowing | -13.99B |
| Free Cash Flow | -612.15B |
| FCF Per Share | -39.84 |
Margins
Gross margin is 31.98%, with operating and profit margins of 13.58% and 6.02%.
| Gross Margin | 31.98% |
| Operating Margin | 13.58% |
| Pretax Margin | 10.58% |
| Profit Margin | 6.02% |
| EBITDA Margin | 24.77% |
| EBIT Margin | 13.58% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 10.50, which amounts to a dividend yield of 0.84%.
| Dividend Per Share | 10.50 |
| Dividend Yield | 0.84% |
| Dividend Growth (YoY) | 23.53% |
| Years of Dividend Growth | 7 |
| Payout Ratio | 36.19% |
| Buyback Yield | -1.90% |
| Shareholder Yield | -1.04% |
| Earnings Yield | 2.25% |
| FCF Yield | -3.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 30, 2021. It was a forward split with a ratio of 5.
| Last Split Date | Jul 30, 2021 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
IDX:HEAL has an Altman Z-Score of 4.1 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.1 |
| Piotroski F-Score | 6 |